NCT01539824 A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01533740 Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients Status COMPLETED Phase N/A
NCT01531621 A Population-based Prospective Study of Metastatic Colorectal Cancer (CRC) Patients in Finland Status RECRUITING Phase N/A
NCT01531595 Study of Bevacizumab in Combination with Alternating XELIRI and XELOX in Metastatic Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01523431 Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients Status COMPLETED Phase PHASE2/PHASE3
NCT01516216 Study of Vitamin D in Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01507545 Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO) Status TERMINATED Phase PHASE2
NCT01472770 A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01460745 A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice Status COMPLETED Phase N/A
NCT01437618 First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer Status COMPLETED Phase N/A
NCT01412957 Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT01410760 PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases Status UNKNOWN Phase EARLY_PHASE1
NCT01399684 A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01387880 Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01386242 Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01363739 Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus Bevacizumab Status UNKNOWN Phase N/A
NCT01345526 Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream Status COMPLETED Phase PHASE2
NCT01328171 FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI) Status COMPLETED Phase PHASE2
NCT01321957 Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2